Rotavirus Infections
Information
- Disease name
- Rotavirus Infections
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05621655 | Active, not recruiting | Phase 2 | Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers | January 8, 2023 | April 2024 |
| NCT00092443 | Completed | Phase 3 | Dose Confirmation Efficacy Study (V260-007) | September 2002 | June 2004 |
| NCT00092456 | Completed | Phase 3 | Consistency Lots Vaccine Study (V260-009) | May 2003 | August 2004 |
| NCT00130832 | Completed | Phase 3 | Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED) | October 2005 | July 2006 |
| NCT00280111 | Completed | Phase 1 | Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants | January 2005 | May 2005 |
| NCT00346892 | Completed | Phase 2 | To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV | November 2001 | |
| NCT00443846 | Completed | Phase 3 | RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016) | February 13, 2007 | October 23, 2007 |
| NCT00090233 | Completed | Phase 3 | Rotavirus Efficacy and Safety Trial (REST)(V260-006) | January 2001 | October 2004 |
| NCT00981669 | Completed | Phase 1 | Rotavirus Vaccine Produced by Butantan Institute | March 2009 | June 2010 |
| NCT01467037 | Completed | Vaccine Effectiveness of RV1 in a Naïve Population | February 2012 | December 2014 | |
| NCT02220439 | Completed | Does the Fecal Microbiome Influence Rotarix Immunogenicity | September 2013 | November 2013 | |
| NCT02538211 | Completed | N/A | The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses | September 2015 | February 2017 |
| NCT02542462 | Completed | Phase 4 | Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study | November 2015 | May 2017 |
| NCT03483116 | Completed | Phase 2 | A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine | June 15, 2018 | January 27, 2020 |
| NCT03870061 | Completed | N/A | Evaluation of an Infant Immunization Encouragement Program in Nigeria | July 1, 2018 | February 20, 2020 |
| NCT05037435 | Completed | Phase 3 | Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years. | June 25, 2018 | July 27, 2018 |
| NCT06080906 | Recruiting | Phase 2 | Phase II Clinical Trial of the Inactivated Rotavirus Vaccine | October 20, 2023 | June 17, 2025 |
| NCT03313128 | Recruiting | SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance | October 1, 2017 | December 31, 2023 | |
| NCT01357174 | Terminated | ROTATEQ™ Post-Marketing Surveillance in the Philippines | October 2007 | September 2010 | |
| NCT00484952 | Unknown status | Surveillance of Hospitalizations Due to Rotavirus Infections Among Children From Israel | September 2007 | September 2009 | |
| NCT03367559 | Unknown status | Phase 3 | Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam | February 8, 2018 | May 2019 |
| NCT01363726 | Unknown status | Surveillance of Rotavirus Gastroenteritis in Children <5 Years | October 2005 | ||
| NCT05212935 | Unknown status | A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy | May 2022 | April 2023 | |
| NCT00757926 | Withdrawn | Phase 1/Phase 2 | Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants | September 2009 | September 2010 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012400